1-4 of 4
biological factors
Close
Sort by
Journal Articles

Optimizing frontline therapy of CLL based on clinical and biological factors

Kirsten Fischer, Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 338–345.
https://doi.org/10.1182/asheducation-2017.1.338
Published: 2017
Journal Articles

Follicular lymphoma: are we ready for a risk-adapted approach?

Brad S. Kahl
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 358–364.
https://doi.org/10.1182/asheducation-2017.1.358
Published: 2017
Journal Articles

Pulmonary Hypertension, Tricuspid Regurgitant Velocity Screening, and the Nitric Oxide Pathway

Kathryn L. Hassell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 419–426.
https://doi.org/10.1182/asheducation-2011.1.419
Published: 2011
Journal Articles

Predicting clinical outcome in CLL: how and why

Tait D. Shanafelt
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 421–429.
https://doi.org/10.1182/asheducation-2009.1.421
Published: 2009